ViroPharma to Present at the ThinkEquity Partners ThinkTank Forum on Hepatitis C and Genzyme Offer for AnorMed Moves Forward.

0 Comments | M2 Presswire, November, 2006

M2 PRESSWIRE-8 November 2006-U.S. Equity News: ViroPharma to Present at the ThinkEquity Partners ThinkTank Forum on Hepatitis C and Genzyme Offer for AnorMed Moves Forward(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:08112006 City of Industry, CA - Biotechnology industry alert provided by U.S.

Equity News. ViroPharma Incorporated (Nasdaq: VPHM) recently announced it will present at the ThinkEquity Partners ThinkTank forum on hepatitis C at 8:20 A.M. ET on Friday, November 10, 2006. The conference is being held at The Ritz Carlton - Midtown, in New York City. ViroPharma's presentation will be webcast live for investors through info@m2.com)).

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)